Phytosomes: A Promising Nanocarrier for Enhanced Delivery of Herbal Compounds in Cancer Therapy
Article Sidebar
PDF downloads: 30
XML-DOAJ downloads: 11
Crossref Citations: 0
Main Article Content
Abstract
Cancer is a life-threatening disease that remains a global health problem, with millions of people diagnosed yearly. Despite significant progress in cancer treatment, conventional chemotherapy still faces several limitations, including poor solubility, low bioavailability, lack of selectivity, and severe side effects. Therefore, alternative therapeutic strategies are necessary to improve cancer therapy. This review aimed to provide an updated overview of phytosome complexes and their potential application in cancer therapy, including their formulation techniques, transportation mechanism through phytosome, and recent investigations on their efficacy in treating different types of cancers. In recent years, nanotechnology has emerged as a promising approach to cancer therapy, as it enables the delivery of therapeutic agents to the tumor site with higher selectivity and efficiency. Phytosomes are a nanotechnology-based drug delivery system conjugating plant extracts or phytoconstituents with phospholipids. This conjugation results in the formation of a complex with improved solubility, stability, and bioavailability. Phytosomes have been shown to enhance the pharmacokinetic profile of phytoactive compounds, allowing for better targeting and sustained release. Phytosomes of curcumin, resveratrol, and quercetin have demonstrated anticancer properties in various in vitro and in vivo models. Moreover, phytosomes have been used to deliver chemotherapeutic agents, such as paclitaxel, docetaxel, and camptothecin, with improved efficacy and reduced toxicity. Phytosome complexes offer a promising platform for cancer therapy due to their ability to enhance the bioavailability and efficacy of phytoactive compounds. Incorporating phytosomes in cancer therapy could lead to the development of more effective and less toxic treatments for different types of cancers. Further studies are needed to elucidate the mechanism of action of phytosomes and to optimize their formulation for clinical use.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Tzenios N. A new hallmark of cancer: Stemness. Special J Med Acad Sci. 2023; 1(1). DOI: https://doi.org/10.58676/sjmas.v1i1.3
Cheng Z, Li M, Dey R, and Chen Y. Nanomaterials for cancer therapy: Current progress and perspectives. J of Hematolo oncolo. 2021; 14(1): 1-27. DOI: https://doi.org/10.1186/s13045-021-01096-0
Hani U, Osmani RAM, Yasmin S, Gowda BJ, Ather H, and Ansari MY, et al. Novel drug delivery systems as an emerging platform for stomach cancer therapy. Pharmaceutics. 2022; 14(8): 1576. DOI: https://doi.org/10.3390/pharmaceutics14081576
Sahu T, Ratre YK, Chauhan S, Bhaskar L, Nair MP, and Verma HK. Nanotechnology based drug delivery system: Current strategies and emerging therapeutic potential for medical science. J Drug Deliv Sci Technol. 2021; 63: 102487. DOI: https://doi.org/10.1016/j.jddst.2021.102487
Chivere VT, Kondiah PP, Choonara YE, and Pillay V. Nanotechnology-based biopolymeric oral delivery platforms for advanced cancer treatment. Cancer. 2020; 12(2): 522. DOI: https://doi.org/10.3390/cancers12020522
Waghule T, Gorantla S, Rapalli VK, Shah P, Dubey SK, Saha RN, et al. Emerging trends in topical delivery of curcumin through lipid nanocarriers: Effectiveness in skin disorders. AAPS Pharm Sci Tech. 2020; 21: 284. DOI: https://doi.org/10.1208/s12249-020-01831-9
Lu H, Zhang S, Wang J, and Chen Q. A review on polymer and lipid-based nanocarriers and its application to nano-pharmaceutical and food-based systems. Front Nutr. 2021; 8: 783831. DOI: https://doi.org/10.3389/fnut.2021.783831
Alharbi WS, Almughem FA, Almehmady AM, Jarallah SJ, Alsharif WK, Alzahrani NM, et al. Phytosomes as an emerging nanotechnology platform for the topical delivery of bioactive phytochemicals. Pharmaceutics. 2021; 13(9): 1475. DOI: https://doi.org/10.3390/pharmaceutics13091475
Pal P, Dave V, Paliwal S, Sharma M, Potdar MB, and Tyagi A. Phytosomes-nanoarchitectures' promising clinical applications and therapeutics. Nanopharm Adv Deliv Syst. 2021. p. 187-216. DOI: https://doi.org/10.1002/9781119711698.ch9
Babazadeh A, Zeinali M, and Hamishehkar H. Nano-phytosome: A developing platform for herbal anticancer agents in cancer therapy. Curr drug target. 2018; 19(2): 170-180. DOI: https://doi.org/10.2174/1389450118666170508095250
Patra S, Pradhan B, Nayak R, Behera C, Rout L, Jena M, et al. Chemotherapeutic efficacy of curcumin and resveratrol against cancer: Chemoprevention, chemoprotection, drug synergism and clinical pharmacokinetics. Semin Cancer Biol; 2021; 73: 310-320. DOI: https://doi.org/10.1016/j.semcancer.2020.10.010
Wani K, Tarawadi K, and Kaul-Ghanekar R. Nanocarriers for delivery of herbal based drugs in breast cancer-an overview. J Nano Res. 2015; 34: 29-40. DOI: https://doi.org/10.4028/www.scientific.net/JNanoR.34.29
Kashyap D, Tuli HS, Yerer MB, Sharma A, Sak K, Srivastava S, et al. Natural product-based nanoformulations for cancer therapy: Opportunities and challenges. Semin Cancer Biol; 2021: 69: 5-23. DOI: https://doi.org/10.1016/j.semcancer.2019.08.014
Sharma P, Verma S, and Misri P. Global need for novel herbal drug formulations. Int J Pharmacog Phytochem Res. 2016; 8: 1535-1544. Available at: http://impactfactor.org/PDF/IJPPR/8/IJPPR,Vol8, Issue9,Article17.pdf
Kaur G, Kaur P, Madaan P, Verma R, Chandel P, Salgotra T, et al. Herbal bioactives in transdermal drug delivery system. Herb bioact-base drug deliv syst. 2022. p. 93-110. DOI: https://doi.org/10.1016/B978-0-12-824385-5.00016-9
Pandey R, Bhairam M, Shukla SS, and Gidwani B. Colloidal and vesicular delivery system for herbal bioactive constituents. DARU J Pharmaceu Sci. 2021; 29(2): 415-438. DOI: https://doi.org/10.1007/s40199-021-00403-x
Das S, and Sharangi AB. Nanotechnology: A potential tool in exploring herbal benefits. In: Thangadurai D, Sangeetha J, Prasad R, editors. Functional bionanomaterials: From biomolecules to nanoparticl. 2020. p. 27-46. DOI: https://doi.org/10.1007/978-3-030-41464-1_2
Dubey SK, Dey A, Singhvi G, Pandey MM, Singh V, and Kesharwani P. Emerging trends of nanotechnology in advanced cosmetics.
Colloids Surf B Biointerfaces. 2022; 214: 112440. DOI: https://doi.org/10.1016/j.colsurfb.2022.112440
Pawar HA, and Bhangale BD. Phytosome as a novel biomedicine: A microencapsulated drug delivery system. J Bioanal Biomed. 2015; 7(1): 6-12. Available at: https://www.hilarispublisher.com/open-access/phytosome-as-a-novel-biomedicine-a-microencapsulated-drug-delivery-system-1948-593X.1000116.pdf
Kumar D, Vats N, Saroha K, and Rana AC. Phytosomes as emerging nanotechnology for herbal drug delivery. In: Saneja A, Panda A, Lichtfouse, E, editors. Sustainable agriculture reviews 43. 2020. p. 217-237. DOI: https://doi.org/10.1007/978-3-030-41838-0_7
Babazadeh A, Jafari SM, and Shi B. Encapsulation of food ingredients by nanophytosomes. Lipid-based nanostructures for food encapsulation purposes. 2019. p. 405-443. DOI: https://doi.org/10.1016/B978-0-12-815673-5.00010-6
Polachi N, Bai G, Li T, Chu Y, Wang X, Li S, et al. Modulatory effects of silibinin in various cell signaling pathways against liver disorders and cancer-A comprehensive review. Eur J Med Chem. 2016; 123: 577-595. DOI: https://doi.org/10.1016/j.ejmech.2016.07.070
Tung BT, Hai NT, and Son PK. Hepatoprotective effect of Phytosome Curcumin against paracetamol-induced liver toxicity in mice. Braz J Pharm Sci. 2017; 53(1): e16136. DOI: https://doi.org/10.1590/s2175-97902017000116136
Shriram RG, Moin A, Alotaibi HF, Khafagy ES, Al Saqr A, Abu Lila AS, et al. Phytosomes as a plausible nano-delivery system for enhanced oral bioavailability and improved hepatoprotective activity of silymarin. Pharmaceuticals. 2022; 15(7): 790. DOI: https://doi.org/10.3390/ph15070790
Tripathy S, Patel DK, Barob L, and Naira SK. A review on phytosomes, their characterization, advancement & potential for transdermal application. J Drug Deliv Ther. 2013; 3(3): 147-152. DOI: https://doi.org/10.22270/jddt.v3i3.508
Rathore P, and Swami G. Planterosomes: A potential phyto-phospholipid carriers for the bioavailability enhancement of herbal extracts. Int J Pharmaceu Sci Res. 2012; 3(3): 737-755. Available at: https://ijpsr.com/bft-article/planterosomes-a-potential-phyto-phospholipid-carriers-for-the-bioavailability-enhancement-of-herbal-extracts/
Abenavoli L, Izzo AA, Milić N, Cicala C, Santini A, and Capasso R. Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases. Phytother Res. 2018; 32(11): 2202-2213. DOI: https://doi.org/10.1002/ptr.6171
Davatgaran-Taghipour Y, Masoomzadeh S, Farzaei MH, Bahramsoltani R, Karimi-Soureh Z, Rahimi R, et al. Polyphenol nanoformulations for cancer therapy: Experimental evidence and clinical perspective. Int J Nanomed. 2017; 12: 2689-2702. DOI: https://doi.org/10.2147/IJN.S131973
Tuli HS, Mittal S, Aggarwal D, Parashar G, Parashar NC, Upadhyay SK, et al. Path of Silibinin from diet to medicine: A dietary polyphenolic flavonoid having potential anticancer therapeutic significance.
Semin Cancer Biol. 2021; 73: 196- 218. DOI: https://doi.org/10.1016/j.semcancer.2020.09.014
Tyagi AK, Agarwal C, Chan DC, and Agarwal R. Synergistic anticancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells. Oncol Rep. 2004; 11(2): 493-499. DOI: https://doi.org/10.3892/or.11.2.493
Singh B, Singh HB, Singh A, Naqvi AH, and Singh BR. Dietary phytochemicals alter epigenetic events and signaling pathways for inhibition of metastasis cascade: Phytoblockers of metastasis cascade. Cancer and Metastasis Rev. 2014; 33: 41-85. DOI: https://doi.org/10.1007/s10555-013-9457-1
Takke A, and Shende P. Nanotherapeutic silibinin: An insight of phytomedicine in healthcare reformation. Nanomed: NBM. 2019; 21: 102057. DOI: https://doi.org/10.1016/j.nano.2019.102057
Baishya R, Hati Boruah JL, Bordoloi MJ, Kumar D, and Kalita P. Novel drug delivery system in phytochemicals. In: Sen S, Chakraborty R, editors. Herb Med India. 2020. p. 175-189. DOI: https://doi.org/10.1007/978-981-13-7248-3_12
Ochi MM, Amoabediny G, Rezayat SM, Akbarzadeh A, and Ebrahimi B. In vitro co-delivery evaluation of novel pegylated nano-liposomal herbal drugs of silibinin and glycyrrhizic acid (nano-phytosome) to hepatocellular carcinoma cells. Cell J. 2016; 18(2): 135-148. Available at: https://pubmed.ncbi.nlm.nih.gov/27540518/
Lazzeroni M, Guerrieri-Gonzaga A, Gandini S, Johansson H, Serrano D, Cazzaniga M, et al. A presurgical study of oral silybin-phosphatidylcholine in patients with early breast cancerlevels of silybin in breast cancer patients. Cancer Prev Res. 2016; 9(1): 89-95. DOI: https://doi.org/10.1158/1940-6207.CAPR-15-0123
Jones OT, Ranmuthu CK, Hall PN, Funston G, and Walter FM. Recognising skin cancer in primary care. Adv Ther. 2020; 37: 603-616. DOI: https://doi.org/10.1007/s12325-019-01130-1
Mazumder A, Dwivedi A, Fox LT, Brümmer A, du Preez JL, Gerber M, et al. In vitro skin permeation of sinigrin from its phytosome complex.
J Pharm Pharmacol. 2016; 68(12): 1577-1583. DOI: https://doi.org/10.1111/jphp.12594
Mazumder A, Dwivedi A, Du Preez JL, and Du Plessis J. In vitro wound healing and cytotoxic effects of sinigrin-phytosome complex.
Int J Pharmaceu. 2016; 498(1-2): 283-293. DOI: https://doi.org/10.1016/j.ijpharm.2015.12.027
Barani M, Sangiovanni E, Angarano M, Rajizadeh MA, Mehrabani M, Piazza S, et al. Phytosomes as innovative delivery systems for phytochemicals: A comprehensive review of literature. Int J Nanomed. 2021; 16: 6983-7022. DOI: https://doi.org/10.2147/IJN.S318416
Matias D, Rijo P, and Pinto Reis C. Phytosomes as biocompatible carriers of natural drugs. Curr Med Chem. 2017; 24(6): 568-589. DOI: https://doi.org/10.2174/0929867323666161028160855
Xie L, Cheng L, and Wei Y. Mitomycin C enhanced the antitumor efficacy of Rocaglamide in colorectal cancer. Pathol Res Prac. 2023; 243: 154350. DOI: https://doi.org/10.1016/j.prp.2023.154350
Gabizon A, Shmeeda H, Tahover E, Kornev G, Patil Y, Amitay Y, et al. Development of promitil®, a lipidic prodrug of mitomycin c in PEGylated liposomes: From bench to bedside. Adv drug deliv Rev. 2020; 154: 13-26. DOI: https://doi.org/10.1016/j.addr.2020.07.027
Wen T, Song L, and Hua S. Perspectives and controversies regarding the use of natural products for the treatment of lung cancer. Cancer Med. 2021; 10(7): 2396-422. DOI: https://doi.org/10.1002/cam4.3660
Hou Z, Li Y, Huang Y, Zhou C, Lin J, Wang Y, et al. Phytosomes loaded with mitomycin C-soybean phosphatidylcholine complex developed for drug delivery. Mol Pharmaceu. 2013; 10(1): 90-101. DOI: https://doi.org/10.1021/mp300489p
Li Y, Wu H, Jia M, Cui F, Lin J, Yang X, et al. Therapeutic effect of folate-targeted and PEGylated phytosomes loaded with a mitomycin C-soybean phosphatidyhlcholine complex. Mol Pharmaceu. 2014; 11(9): 3017-3026. DOI: https://doi.org/10.1021/mp5001873
Kocaadam B, and Şanlier N. Curcumin, an active component of turmeric (Curcuma longa), and its effects on health. Crit Rev Food Sci Nutr. 2017; 57(13): 2889-2895. DOI: https://doi.org/10.1080/10408398.2015.1077195
Farnood PR, Pazhooh RD, Asemi Z, and Yousefi B. Targeting signaling pathway by curcumin in osteosarcoma. Curr Mol Pharmacol. 2023; 16(1): 71-82. DOI: https://doi.org/10.2174/1874467215666220408104341
Hussain Y, Alam W, Ullah H, Dacrema M, Daglia M, Khan H, et al. antimicrobial potential of curcumin: Therapeutic potential and challenges to clinical applications. Antibiotics. 2022; 11(3): 322. DOI: https://doi.org/10.3390/antibiotics11030322
Purpura M, Lowery RP, Wilson JM, Mannan H, Münch G, Razmovski-and Naumovski V. Analysis of different innovative formulations of curcumin for improved relative oral bioavailability in human subjects. Eur J Nut. 2018; 57: 929-938. DOI: https://doi.org/10.1007/s00394-016-1376-9
Rashidzadeh H, Salimi M, Sadighian S, Rostamizadeh K, and Ramazani A. In vivo antiplasmodial activity of curcumin-loaded nanostructured lipid carriers. Curr Drug Deliv. 2019; 16(10): 923-930. DOI: https://doi.org/10.2174/1567201816666191029121036
Khanna D, Sethi G, Ahn KS, Pandey MK, Kunnumakkara AB, Sung B, et al. Natural products as a gold mine for arthritis treatment. Curr Opin Pharmacol. 2007; 7(3): 344-351. DOI: https://doi.org/10.1016/j.coph.2007.03.002
Khan J, Alexander A, Saraf S, and Saraf S. Recent advances and future prospects of phyto-phospholipid complexation technique for improving pharmacokinetic profile of plant actives. J Control Release. 2013; 168(1): 50-60. DOI: https://doi.org/10.1016/j.jconrel.2013.02.025
Mishra DK, Shandilya R, and Mishra PK. Lipid based nanocarriers: A translational perspective. Nanomedicine: NBM. 2018; 14(7): 2023-2050. DOI: https://doi.org/10.1016/j.nano.2018.05.021
Bonifacio BV, da Silva PB, Ramos MAdS, Negri KMS, Bauab TM, and Chorilli M. Nanotechnology-based drug delivery systems and herbal medicines: A review. Int J Nanomed. 2014: 1-15. DOI: https://doi.org/10.2147/IJN.S52634
Bilia AR, Piazzini V, Guccione C, Risaliti L, Asprea M, Capecchi G, et al. Improving on nature: The role of nanomedicine in the development of clinical natural drugs. Planta Medica. 2017; 83(5): 366-381. DOI: https://doi.org/10.1055/s-0043-102949
Rana M, Kumar A, and Rana AJ. Drug delivery through targeted approach with special references to phytosomes. In: Tyagi RK, Garg N, Shukla R, Bisen PS, editors. Role of novel drug delivery vehicles nanobiomed. 2020. p. 125. DOI: https://doi.org/10.5772/intechopen.86644
Li J, Wang X, Zhang T, Wang C, Huang Z, Luo X, et al. A review on phospholipids and their main applications in drug delivery systems. Asian J Pharmaceu Sci. 2015; 10(2): 81-98. DOI: https://doi.org/10.1016/j.ajps.2014.09.004
Thanuja M, Anupama C, and Ranganath SH. Bioengineered cellular and cell membrane-derived vehicles for actively targeted drug delivery: So near and yet so far. Adv Drug Deliv Rev. 2018; 132: 57-80. DOI: https://doi.org/10.1016/j.addr.2018.06.012
Allen TM, and Cullis PR. Liposomal drug delivery systems: From concept to clinical applications. Adv Drug Deliv Rev. 2013; 65(1): 36-48. DOI: https://doi.org/10.1016/j.addr.2012.09.037
Rasaee S, Ghanbarzadeh S, Mohammadi M, and Hamishehkar H. Nano phytosomes of quercetin: A promising formulation for fortification of food products with antioxidants. Pharmaceu Sci. 2014; 20(3): 96-101. Available at: https://ps.tbzmed.ac.ir/Article/PHARM_2238_20140916092941